4.6 Article

Structure-based Analysis of VDAC1 Protein DEFINING OLIGOMER CONTACT SITES

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 287, 期 3, 页码 2179-2190

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.268920

关键词

-

资金

  1. Israel Science Foundation [649/09]
  2. Direct For Biological Sciences
  3. Div Of Biological Infrastructure [1062328] Funding Source: National Science Foundation
  4. Direct For Mathematical & Physical Scien
  5. Division Of Mathematical Sciences [800183, 0800257] Funding Source: National Science Foundation

向作者/读者索取更多资源

The outer mitochondrial membrane protein, the voltage-dependent anion channel (VDAC), is increasingly implicated in the control of apoptosis. Oligomeric assembly of VDAC1 was shown to be coupled to apoptosis induction, with oligomerization increasing substantially upon apoptosis induction and inhibited by apoptosis blockers. In this study, structure-and computation-based selection of the predicated VDAC1 dimerization site, in combination with site-directed mutagenesis, cysteine replacement, and chemical cross-linking, were employed to identify contact sites between VDAC1 molecules in dimers and higher oligomers. The predicted weakly stable beta-strands were experimentally found to represent the interfaces between VDAC1 monomers composing the oligomer. Replacing hydrophobic amino acids with charged residues in beta-strands 1, 2, and 19 interfered with VDAC1 oligomerization. The proximity of beta-strands 1, 2, and 19 within the VDAC1 dimer and the existence of other association sites involving beta-strand 16 were confirmed when a cysteine was introduced at defined positions in cysteineless VDAC1 mutants, together with the use of cysteine-specific cross-linker bis(maleimido) ethane. Moreover, the results suggest that VDAC1 also exists as a dimer that upon apoptosis induction undergoes conformational changes and that its oligomerization proceeds through a series of interactions involving two distinct interfaces. Dissection of VDAC1 dimerization/oligomerization as presented here provides structural insight into the oligomeric status of cellular VDAC1 under physiological and apoptotic conditions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

m6A modification controls the innate immune response to infection by targeting type I interferons

Roni Winkler, Ella Gillis, Lior Lasman, Modi Safra, Shay Geula, Clara Soyris, Aharon Nachshon, Julie Tai-Schmiedel, Nehemya Friedman, Vu Thuy Khanh Le-Trilling, Mirko Trilling, Michal Mandelboim, Jacob H. Hanna, Schraga Schwartz, Noam Stern-Ginossar

NATURE IMMUNOLOGY (2019)

Article Cell Biology

Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation

Heather Lee, Suying Bao, Yingzhi Qian, Shay Geula, Juliana Leslie, Chaolin Zhang, Jacob H. Hanna, Lei Ding

NATURE CELL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

VDAC1 and the TSPO: Expression, Interactions, and Associated Functions in Health and Disease States

Varda Shoshan-Barmatz, Srinivas Pittala, Dario Mizrachi

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biotechnology & Applied Microbiology

A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model

Srinivas Pittala, Yakov Krelin, Yael Kuperman, Varda Shoshan-Barmatz

MOLECULAR THERAPY (2019)

Article Cell Biology

Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept

Tasleem Arif, Oriel Stern, Srinivas Pittala, Vered Chalifa-Caspi, Varda Shoshan-Barmatz

Article Cell Biology

The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus

Srinivas Pittala, Idan Levy, Soumasree De, Swaroop Kumar Pandey, Nataly Melnikov, Tehila Hyman, Varda Shoshan-Barmatz

Article Oncology

The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link

Zohar Amsalem, Tasleem Arif, Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, Varda Shoshan-Barmatz

CANCERS (2020)

Article Oncology

VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment

Erez Zerbib, Tasleem Arif, Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, Varda Shoshan-Barmatz

Summary: Tumors consist of proliferating cancer cells and their microenvironment, including extracellular matrix, blood vessels, and tissue cells. Understanding molecular interactions between cancer cells and the microenvironment is crucial for developing therapeutic strategies. Depleting VDAC1 in cancer cells leads to metabolic reprogramming, inhibits tumor growth, and disrupts tumor-host interactions, making it a potential therapeutic target for inhibiting cancer progression.

CANCERS (2021)

Editorial Material Oncology

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets

Joao Pessoa, Marta Martins, Sandra Casimiro, Carlos Perez-Plasencia, Varda Shoshan-Barmatz

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks

Swaroop Kumar Pandey, Renen Machlof-Cohen, Manikandan Santhanam, Anna Shteinfer-Kuzmine, Varda Shoshan-Barmatz

Summary: This study found that VDAC1 is overexpressed in patients with mesothelioma and its levels increase with disease stage, leading to low survival rates. Silencing VDAC1 expression can inhibit cell proliferation of mesothelioma cancer cells and cause metabolic reprogramming. VDAC1 silencing also has effects on modulating the tumor microenvironment and inflammation, eliminating cancer stem cells, and inducing cell differentiation.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS

Anna Shteinfer-Kuzmine, Shirel Argueti-Ostrovsky, Marcel F. Leyton-Jaimes, Uttpal Anand, Salah Abu-Hamad, Ran Zalk, Varda Shoshan-Barmatz, Adrian Israelson

Summary: This study suggests that the interaction between VDAC1 and SOD1 is involved in the pathogenesis of ALS. By inhibiting VDAC1 oligomerization, it is possible to reduce cell apoptosis and related processes caused by mutant SOD1, thus improving muscle function in ALS patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

The Multicellular Effects of VDAC1 N-Terminal-Derived Peptide

Uttpal Anand, Anna Shteinfer-Kuzmine, Gal Sela, Manikandan Santhanam, Benjamin Gottschalk, Rajaa Boujemaa-Paterski, Ohad Medalia, Wolfgang F. Graier, Varda Shoshan-Barmatz

Summary: The mitochondrial protein VDAC1 plays a crucial role in regulating various cellular processes, including metabolism, apoptosis, and cell signaling. In this study, a short peptide derived from the N-terminal region of VDAC1 was designed to improve cellular stability and activity. The peptide exhibited multiple effects on cancer cells, such as apoptosis induction, autophagy, senescence, and cell adhesion. Furthermore, the peptide altered the expression of proteins associated with cell metabolism and signaling. These findings highlight the importance of VDAC1 in controlling diverse cellular functions through its interaction with other proteins.

BIOMOLECULES (2022)

Article Oncology

Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract

Almog Nadir, Anna Shteinfer-Kuzmine, Swaroop Kumar Pandey, Juan Ortas, Daniel Kerekes, Varda Shoshan-Barmatz

Summary: This study identified three different plant extracts that can effectively induce cell death and focused on the most potent extract. The extract kills tumor cells through multiple mechanisms, including impairing cell energy and metabolism, generating reactive oxygen species, increasing intracellular calcium levels, and inducing mitochondria-mediated apoptosis. In a mouse model of glioblastoma, the extract inhibits tumor growth and induces massive tumor cell death, including cancer stem cells, by inhibiting blood supply and modulating the tumor microenvironment. These findings suggest that the plant extract has potential as a cancer therapeutic.

CANCERS (2023)

Review Biochemistry & Molecular Biology

VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases

Varda Shoshan-Barmatz, Anna Shteinfer-Kuzmine, Ankit Verma

BIOMOLECULES (2020)

Article Cell Biology

Context-dependent functional compensation between Ythdf m(6)A reader proteins

Lior Lasman, Vladislav Krupalnik, Sergey Viukov, Nofar Mor, Alejandro Aguilera-Castrejon, Dan Schneir, Jonathan Bayerl, Orel Mizrahi, Shani Peles, Shadi Tawil, Shashank Sathe, Aharon Nachshon, Tom Shani, Mirk Zerbib, Itay Kilimnik, Stefan Aigner, Archana Shankar, Jasmine R. Mueller, Schraga Schwartz, Noam Stern-Ginossar, Gene W. Yeo, Shay Genla, Noa Novershtern, Jacob H. Hanna

GENES & DEVELOPMENT (2020)

暂无数据